Genome Editing for the treatment of human Disease Network

GenEHumDi recommended activities

Events in September 2024

MMonday	TTuesday	WWednesday	TThursday	FFriday	SSaturday	SSunday
26August 26, 2024	27August 27, 2024	28August 28, 2024	29August 29, 2024	30August 30, 2024	31August 31, 2024	1September 1, 2024
2September 2, 2024	3September 3, 2024	4September 4, 2024●(1 event) Close International Society for Cell & Gene Therapy (ISCT) | Europe 2024 Regional Meeting September 4, 2024 – September 6, 2024 Read more	5September 5, 2024●(1 event) Close International Society for Cell & Gene Therapy (ISCT) | Europe 2024 Regional Meeting September 4, 2024 – September 6, 2024 Read more	6September 6, 2024●(1 event) Close International Society for Cell & Gene Therapy (ISCT) | Europe 2024 Regional Meeting September 4, 2024 – September 6, 2024 Read more	7September 7, 2024	8September 8, 2024
9September 9, 2024	10September 10, 2024	11September 11, 2024	12September 12, 2024	13September 13, 2024	14September 14, 2024	15September 15, 2024
16September 16, 2024	17September 17, 2024	18September 18, 2024●(1 event) Close WG2 MEETING September 18, 2024 Read more	19September 19, 2024	20September 20, 2024	21September 21, 2024	22September 22, 2024
23September 23, 2024	24September 24, 2024	25September 25, 2024	26September 26, 2024	27September 27, 2024	28September 28, 2024	29September 29, 2024
30September 30, 2024	1October 1, 2024	2October 2, 2024	3October 3, 2024●(1 event) Close 2:00 pm: Coupling Genome editing tools with Delivery systems 2:00 pm – 6:00 pm October 3, 2024 – October 4, 2024 Read more	4October 4, 2024●(1 event) Close 2:00 pm: Coupling Genome editing tools with Delivery systems 2:00 pm – 6:00 pm October 3, 2024 – October 4, 2024 Read more	5October 5, 2024	6October 6, 2024

Last GenEHumDi Blog entry

Coupling Genome Editing Tools with Delivery Systems

GenE-HumDi Workshop in Barcelona, 3-4 October 2024 UPDATE 10/09/2024:NEW DEADLINE TO BOOK YOUR SEAT: SEPTEMBER 15th!Registration for students, early career ...
Read More

Welcome to the Genome Editing for the treatment of human Disease Network (GeneHumdi | COST action CA21113) Website. We are Academia and industry scientist, translational scientist, clinicians, regulatory agents, and industry partners dedicated to the improvement and translation of Gene Editing protocols to treat diseases lacking sound medical care or susceptible of increase safety and control of the therapeutic interventions through the implementation of precision gene medicine.

Recent advances on genome editing (GE) technologies have opened the possibility of treating diseases through precise modifications of patients’ genomes. Impressive results have been achieved on animal models of several genetic disorders, infectious diseases as well as cancer and several clinical trials are already on going. However, the inadequate integration of the results of academic research into the research development strategy of pharmaceutical companies, the insufficient interest of academic institution in regulatory science and the absence of established standards to well acceptable risk-benefit ratio by regulatory agencies, preclude its general application for treating human diseases. Therefore, the translation of the GE technologies to address public health needs, require a strong collaboration between basic and clinical research, regulatory bodies and the different stake holders involved for each application. There are several networks to improve or analyse GE technologies for different applications, however, no one cover all the actors involved in gene therapy translation.

The principal aim of the GeneHumdi Action is to bring together pharmaceutical companies, academic institution, science and regulatory agencies, biotechnology firms, patient advocacy association and information technology, in order to tackle knowledge fragmentation with the aim to accelerate the translation of GE technologies to the treatment of human diseases. GeneHumdi is supported by COST (European Cooperation in Science and Technology) which is a funding organisation for research and innovation networks operating in Europe since 1971. In their organigram, GeneHumdi nourishes from the ideas exchange of Management Committee (MC) members from over 24 EU Countries and MC and other members are organized into Working Groups (WG) to distribute GeneHumdi workload and allocate specific question to dedicated experts in each field.